In addition, compared to mice with a single deficiency in PARP1, a single deficiency in PARP2, or normal control mice, breast cancer mice with PARP1/2 double deficiencies have a higher percentage of CD11b+DCs in cancer tissues (129). Here, PARP2 is linked to breast carcinoma.